Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Diffusion-weighted imaging-gadolinium enhancement mismatch sign in diffuse midline glioma.

European journal of radiology - 1 Feb 2022

Ikeda Koki, Kolakshyapati Manish, Takayasu Takeshi, Amatya Vishwa Jeet, Takano Motoki, Yonezawa Ushio, Taguchi Akira, Onishi Shumpei, Takeshima Yukio, Sugiyama Kazuhiko, Yamasaki Fumiyuki

Abstract excerpt

BACKGROUND: Diffuse midline glioma (DMG), H3 K27M-mutant including diffuse intrinsic pontine glioma (DIPG) is a disease with dismal prognosis. We focused on diffusion-weighted imaging (DWI) and gadolinium enhanced T1WI (Gd), especially high intensity on DWI at non-enhanced lesion, i.e. DWI-Gd mismatch sign, to establish as an imaging biomarker of DMG patients. MATERIALS AND METHODS: Our institutional review board...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Contrast Media
Share to Gadolinium

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Glioma

Share to Mutation

Source

Identifiers

PMID: 35051691
DOI: 10.1016/j.ejrad.2021.110103

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Diffusion-weighted imaging-gadolinium enhancement mismatch sign in diffuse midline glioma.PMID 35051691Read ↗

Dynamic susceptibility contrast-MRI parameters, ADC values, and the T2-FLAIR mismatch sign are useful to differentiate between H3-mutant and H3-wild-type high-grade midline glioma.Semantic proximity Read ↗

Diffusion and perfusion imaging biomarkers of H3 K27M mutation status in diffuse midline gliomas.Semantic proximity Read ↗

Prediction of H3K27M mutation status of diffuse midline gliomas using MRI features.Semantic proximity Read ↗

[Diffuse midline glioma].Semantic proximity Read ↗

Can Conventional MRI Features Predict H3K27M Mutation Status of Diffuse Midline Gliomas?Semantic proximity Read ↗

Characteristics of H3K27M-mutant diffuse gliomas with a non-midline location.Semantic proximity Read ↗

A new subtype of diffuse midline glioma, H3 K27 and BRAF/FGFR1 co-altered: a clinico-radiological and histomolecular characterisation.Semantic proximity Read ↗

T2-FLAIR Mismatch Sign and Response to Radiotherapy in Diffuse Intrinsic Pontine Glioma.Semantic proximity Read ↗

H3K27M mutant diffuse midline glioma: a case report.Semantic proximity Read ↗

[Clinical Findings of Thalamic and Brainstem Glioma Including Diffuse Midline Glioma, H3K27M Mutant:A Clinical Study].Semantic proximity Read ↗

A validated prognostic nomogram for patients with H3 K27M-mutant diffuse midline glioma.Semantic proximity Read ↗

Clinicohistoradiological and surgical outcome in diffuse midline glioma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.